Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Cancer

Experts advocate annual prostate screenings for men with BRCA mutations

IN FULL

The Independent UK

Baby diagnosed ‘completely out of the blue’ with rare cancer in genetic screening

The study will help inform the Government’s long-term ambition to offer genomic sequencing to all newborns

The Independent UK

Men with BRCA gene mutations ‘should be given annual prostate cancer checks’

The UK National Screening Committee is reviewing the evidence for an NHS prostate cancer screening programme.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Cancer experts warn these men should have prostate screenings every year

BRCA gene mutations are linked to a higher chance of developing prostate cancer at a younger age and in a more aggressive form

The Independent UK

Baby Freddie’s ‘completely out of the blue’ cancer detected by genetic screening

The family were taking part in a study which is screening newborn babies in England for dozens of genetic conditions.

The Independent UK

64-Year-Old Blames Johnson & Johnson for Her Ovarian Cancer — Joins 3,000 Suing the Pharma Giant

UK's first talc cancer group claim accuses Johnson & Johnson and Kenvue of failing to warn about asbestos risk — £1 billion suit backed by 3,000 claimants.

International Business Times UK

Dramatic increase in American adults who meet a new definition of obesity: ‘This is astounding’

Obesity linked to more than 40 diseases including certain cancers

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Ibuprofen: how an everyday drug might offer protection against cancer

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests this everyday drug might be doing more than easing discomfort. It could also have anti-cancer properties.

The Conversation

Beloved ‘Hamilton’ wardrobe stylist fired from show after beating stage 3 cancer, lawsuit says

Exclusive: Kimberly Mark, a theatrical dresser brought to ‘Hamilton’ a decade ago by actor Leslie Odom Jr., says she was unlawfully terminated by producers of the Tony-, Grammy-, and Pulitzer Prize-winning production

The Independent UK

Thousands in UK take legal action against Johnson & Johnson over alleged talc cancer link

High court claim says company knowingly sold product containing asbestos and ‘concealed’ risk to public

The Guardian - UK

Kat Timpf says she faced ‘life and death’ in health update amid breast cancer diagnosis

The comedian was diagnosed with breast cancer in February

The Independent UK

Pankaj Dheer Cause of Death: Remembering the Actor Behind Mahabharata's 'Karna'

Veteran actor Pankaj Dheer, famed for playing Karna in Mahabharat, passed away in Mumbai after a prolonged cancer battle. His courage and legacy live on.

International Business Times UK

This potential Google AI cancer treatment breakthrough could be AI's moonshot moment

Google has announced that its Gemma AI model may have helped discover a new cancer therapy pathway – and that's the kind of AI story we can all get behind.

TechRadar

‘When I was a child, everyone used it’: woman blames Johnson & Johnson talc for her cancer

Sue Rizzello is among thousands in UK suing the firm, which denies selling baby powder containing asbestos

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Merck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients

Merck Co. Inc. (NYSE:MRK) announced data from the Phase 3 KEYNOTE-B96 trial (ENGOT-ov65) of Keytruda (pembrolizumab) in combination with chemotherapy (paclitaxel) with or without Roche Holdings AG’s (OTC:RHHBY) Avastin (bevacizumab).

Benzinga

Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims

Thousands of claimants in the U.K. are suing Johnson Johnson (NYSE:JNJ), accusing the healthcare giant of knowingly selling asbestos-contaminated talcum powder that allegedly caused cancer in consumers. The case, involving roughly 3,000 individuals, is one of the largest product liability claims of its kind to reach the High Court in…

Benzinga

Johnson & Johnson Reportedly Faces Major UK Lawsuit Over Baby Powder Cancer Risks

A legal claim involving 3,000 people has been reportedly filed against Johnson Johnson (NYSE:JNJ) in the U.K., alleging that the company knowingly sold asbestos-contaminated baby powder.

The Guardian - UK

‘Chuck was breaking beer bottles over his own head’: thrash metal legends Testament on 40 years of mayhem

After their lead singer shed his glam rock spandex, the band became rivals to thrash’s Big Four. Still releasing potent high-octane riffage, they retread their path through cancer scares and jazz detours

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Johnson & Johnson faces UK lawsuit over cancer claims

IN FULL

AAP

Why ski great is seeking 20-year Paralympic comeback

Alpine skiing great Michael Milton says he was inspired by a fellow Australian sporting star in his bid to compete at his sixth Winter Paralympics.

Woman & Home

‘My friend keeps making my illness all about her – how can I get her to support me?’

Relationship expert and woman&home columnist Anna Richardson helps a reader with a friendship problem

The Independent UK

Thousands sue Johnson & Johnson in UK over baby powder cancer claims

The pharmaceutical company has been accused of ‘concealing’ the risk to the public for decades

AAP

'Fake cancer' mum admits $11k deception, harm charges

A mother has pleaded guilty to deception charges over a scam in which she solicited donations after faking her six-year-old son's cancer diagnosis.

The Independent UK

New wearable UV detector can monitor exposure and prevent sunburn

Prolonged exposure to UVA accelerates skin ageing and increases the risk of cancer, but this wearable device could signal when it hits dangerous levels

MarketBeat

Tempus AI Hits $100—Are Shares Due for a Pullback?

After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction.

1 … 73 74 75 76

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.